Search clinical trials for: Placebo A

Total 63092 results

Novo Nordisk A/S

Completed

A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity

Obesity

United States
SK Chemicals Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670

Endometriosis

Korea, Republic of
Contera Pharma
Bukwang Pharmaceutical

Active, not recruiting

A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia (ASTORIA)

Dyskinesias

France, Germany, Italy, Korea, Republic of, Spain
AstraZeneca
Parexel

Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants

Healthy Participants

United States
BiomX, Inc.
Maruho Co., Ltd.

Not yet recruiting

A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Universitaire Ziekenhuizen KU Leuven

Completed

Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus (AREBAG)

Type 2 Diabetes Mellitus

Belgium
Phoenix Eagle Company

Suspended

Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers

Pressure Ulcer | Venous Ulcer

Australia
BiomX, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults

Healthy Volunteers

United States
Eisai Inc.

Completed

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

Alzheimer's Disease

United States
Novo Nordisk A/S

Recruiting

A Research Study of a New Medicine (NNC0650-0013) in Healthy Men

Healthy Participants

Germany
Yuji KUMAGAI
Aetas Pharma Co. Ltd.

Completed

First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects

Healthy Volunteers

Japan
Kitasato University
Aetas Pharma Co. Ltd.

Completed

Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects

Healthy Volunteers

Japan
Anthera Pharmaceuticals

Completed

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus (PEARL-SC)

Systemic Lupus Erythematosus

United States, Argentina, Brazil, Chile, Colombia, Hong Kong, India, Mexico, Peru, Philippines, Taiwan
Mansoura University

Completed

Endometrial Scratching Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization With Previous IVF Failure (ESICOHF)

Infertility

Egypt
Zhejiang University

Completed

The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia

Hyperlipoproteinemia
A-Mansia Biotech S.A.

Completed

Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS

Irritable Bowel Syndrome

Germany
Novo Nordisk A/S

Completed

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Anthera Pharmaceuticals

Withdrawn

MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP

Idiopathic Thrombocytopenic Purpura | Immune Thrombocytopenic Purpura
SciNeuro

Completed

A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease

Neurodegenerative Diseases | Alzheimer's Disease

Australia
Kitasato University
Aetas Pharma Co. Ltd.

Unknown

First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation

Paroxysmal Atrial Fibrillation

Japan
Galderma R&D

Completed

Safety and Efficacy of Nemolizumab in PN

Prurigo Nodularis

Germany, Poland, France, Austria
OliPass Australia Pty Ltd
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

Osteoarthritis

Australia
PHARMENTERPRISES LLC

Not yet recruiting

Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19

SARS-CoV-2 Infection | Lung Fibrosis
ViiV Healthcare
GlaxoSmithKline

Not yet recruiting

First Time in Human Study of Long Acting VH4524184 Formulations

HIV Infections

United States
S-Infinity Pharmaceuticals Co., Ltd

Recruiting

A Phase I Study of XH-S002 in Healthy Volunteers

Healthy Adults

China
S-Infinity Pharmaceuticals Co., Ltd

Recruiting

A Phase 1 Study of XH-S003 in Healthy Volunteers

Healthy

Australia
Valbiotis
Biofortis Mérieux NutriSciences

Completed

Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia (Lipiback)

Hypercholesterolemia | Hypertriglyceridemia

France
Central Institute of Mental Health, Mannheim

Completed

Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain

Chronic Lower Back Pain | Healthy Control Subjects

Germany
Idorsia Pharmaceuticals Ltd.

Completed

A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

Healthy Subjects

Netherlands
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder

Overactive Bladder

Korea, Republic of
GLWL Research Inc.

Terminated

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01

Diabetes Mellitus, Type 2

United States
Inipharm Australia Pty Ltd

Recruiting

A Study of INI-822 in Healthy Volunteers and Participants With Non-alcoholic Steatohepatitis (NASH) or Presumed NASH

Non-alcoholic Steatohepatitis

Australia
Walter Reed Army Medical Center

Unknown

Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain

Chronic Low Back Pain

United States
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Terminated

Targeted Investigation of Microbiome Elimination (TIME-1)

Atopic Dermatitis

United States
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

COVID-19

Japan
BiomX, Inc.

Active, not recruiting

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Cystic Fibrosis | Chronic Pseudomonas Aeruginosa Infection

United States, Israel, Spain, Czechia, Netherlands
Quark Pharmaceuticals

Completed

A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

Acute Renal Failure | Injury of Kidney

United States, Israel, Switzerland
Pharmaxis

Recruiting

Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder

REM Sleep Behavior Disorder

Australia, United Kingdom
Derming SRL

Completed

Efficacy and Tolerance Evaluation of a Topical "Revitalizing" Face Day Cream

Healthy

Italy
Dalhousie University
ImmunoVaccine Technologies, Inc. (IMV Inc.)

Completed

A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine

Respiratory Syncytial Virus

Canada
AceLink Therapeutics, Inc.
Novotech (Australia) Pty Limited

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Autosomal Dominant Polycystic Kidney

Australia
Pharmacobio

Recruiting

A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People

Alzheimer Disease

Korea, Republic of
Verona Pharma plc
Iqvia Pty Ltd

Completed

A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease

COPD

United Kingdom
Sunshine Lake Pharma Co., Ltd.

Recruiting

A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)

China
Ventyx Biosciences, Inc

Terminated

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Psoriatic Arthritis

United States, Bulgaria, Czechia, Germany, Hungary, Poland, Spain
Novo Nordisk A/S

Completed

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Mereo BioPharma
Novartis

Terminated

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

Acute Kidney Injury

Taiwan, United States, Israel
Chung Shan Medical University
Grape King Bio Ltd.

Completed

Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations

Cognition Disorders in Old Age | fMRI | Vision | Supplement

Taiwan
Daewoong Pharmaceutical Co. LTD.

Unknown

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease

Non-Erosive Gastroesophageal Reflux Disease

Korea, Republic of
Takeda

Completed

A Study of TAK-105 in Healthy Adults

Healthy Volunteers

United States

3

Subscribe